Nuvation Bio  logo
Nuvation Bio NUVB
€ 4.04 -1.42%
report update icon

Quartalsbericht 2026-Q2
hinzugefügt 06.08.2026

Nuvation Bio Kurshistorie | NUVB

Kurshistorie Jährlich Nuvation Bio

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.83 1.88 1.89 1.66 6.1 10.2 - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
10.2 1.66 4.6

Kurshistorie anderer Aktien in der Pharmaeinzelhändler

Name Kurshistorie Preis % 24h Marktkapitalisierung Land
FSD Pharma FSD Pharma
HUGE
1.31 - 5743.5 % $ 69.7 M canadaCanada
BioAtla BioAtla
BCAB
0.16 $ 1.74 0.64 % $ 102 M usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
24.9 - - $ 3.85 B usaUSA
ARCA biopharma ARCA biopharma
ABIO
28.8 - 1052.0 % $ 415 M usaUSA
Acasti Pharma Acasti Pharma
ACST
3.37 - 4.01 % $ 150 M canadaCanada
ADiTx Therapeutics ADiTx Therapeutics
ADTX
0.98 - - $ 374 usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
5.72 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
13 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
12 - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.17 - 1.93 % $ 17.4 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
2.13 - 10.36 % $ 9.8 M usaUSA
AlloVir AlloVir
ALVR
9.78 - 4.14 % $ 49.1 M usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
22 - - $ 5.18 B usaUSA
Athira Pharma Athira Pharma
ATHA
0.42 - - $ 269 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
0.42 - -52.27 % $ 4.45 M usaUSA
AVROBIO AVROBIO
AVRO
1.27 - 1083.1 % $ 745 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
74.2 - - $ 96.9 B britainBritain
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
1.26 - -2.5 % $ 5.88 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
185 - 0.49 % $ 251 B cayman-islandsCayman-islands
Bio-Path Holdings Bio-Path Holdings
BPTH
3.23 - - $ 100 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
1 - -3.03 % $ 260 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
5.67 - -0.88 % $ 598 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
0.43 - -16.75 % $ 25.8 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
0.25 - -5.98 % $ 34.1 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
4.9 - -4.36 % $ 27 M usaUSA
Diffusion Pharmaceuticals Diffusion Pharmaceuticals
DFFN
4.4 - 11.68 % $ 8.97 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
11 - -5.68 % $ 8.28 M usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
0.7 - - $ 40.5 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
2.7 - - $ 661 M usaUSA
Evofem Biosciences Evofem Biosciences
EVFM
0.8 - 7.55 % $ 38.1 M usaUSA
Eyenovia Eyenovia
EYEN
0.96 - 49.81 % $ 13.2 M usaUSA
FibroGen FibroGen
FGEN
1.85 - - $ 889 M usaUSA
Homology Medicines Homology Medicines
FIXX
1.33 - 0.77 % $ 53.4 M usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
14.3 - - $ 4.47 B usaUSA
Frequency Therapeutics Frequency Therapeutics
FREQ
15 - - $ 528 M usaUSA
Galecto Galecto
GLTO
0.88 - - $ 762 M danmarkDanmark
GlycoMimetics GlycoMimetics
GLYC
0.28 - 9357.83 % $ 1.01 B usaUSA
Graybug Vision Graybug Vision
GRAY
0.44 - -11.23 % $ 9.65 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
0.14 - -32.59 % $ 7.61 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
0.22 - 1.35 % $ 17.8 M chinaChina
Hepion Pharmaceuticals Hepion Pharmaceuticals
HEPA
0.04 - -18.79 % $ 39.3 K usaUSA
Hoth Therapeutics Hoth Therapeutics
HOTH
0.81 - - $ 18.8 M usaUSA
IMARA IMARA
IMRA
6.32 - 15.96 % $ 663 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
15.5 - - $ 1.45 B britainBritain
KemPharm KemPharm
KMPH
5.81 - -0.34 % $ 200 M usaUSA
Kezar Life Sciences Kezar Life Sciences
KZR
6.2 - - $ 53.3 M usaUSA
Lixte Biotechnology Holdings Lixte Biotechnology Holdings
LIXT
3.07 - - $ 63.4 M usaUSA
Magenta Therapeutics Magenta Therapeutics
MGTA
0.7 - -7.74 % $ 41.6 M usaUSA
NovaBay Pharmaceuticals NovaBay Pharmaceuticals
NBY
1.22 - - $ 11.3 M usaUSA
NeuroBo Pharmaceuticals NeuroBo Pharmaceuticals
NRBO
4.09 - 0.43 % $ 12 M usaUSA